Abstract: Provided is a method for configuring a gateway. The method may include a gateway monitoring current version data stored on at least one first server. The current version data may be associated with a current version of a configuration file. The first server may be remote from the gateway. The current version data may be modified at the first server. In response to the gateway determining that the current version data stored on the first server has been modified, a configuration service may be invoked to retrieve the current version of the configuration file from at least one repository based on the current version data. The repository may include at least one second server remote from the gateway and the first server. The gateway may store a copy of the current version of the configuration file retrieved by the configuration service. A system and computer program product are also disclosed.

Abstract: Provided is a method for configuring a gateway. The method may include a gateway monitoring current version data stored on at least one first server. The current version data may be associated with a current version of a configuration file. The first server may be remote from the gateway. The current version data may be modified at the first server. In response to the gateway determining that the current version data stored on the first server has been modified, a configuration service may be invoked to retrieve the current version of the configuration file from at least one repository based on the current version data. The repository may include at least one second server remote from the gateway and the first server. The gateway may store a copy of the current version of the configuration file retrieved by the configuration service. A system and computer program product are also disclosed.

Abstract: Provided is a method for configuring a gateway. The method may include a gateway monitoring current version data stored on at least one first server. The current version data may be associated with a current version of a configuration file. The first server may be remote from the gateway. The current version data may be modified at the first server. In response to the gateway determining that the current version data stored on the first server has been modified, a configuration service may be invoked to retrieve the current version of the configuration file from at least one repository based on the current version data. The repository may include at least one second server remote from the gateway and the first server. The gateway may store a copy of the current version of the configuration file retrieved by the configuration service. A system and computer program product are also disclosed.

Abstract: Provided is a method for configuring a gateway. The method may include a gateway monitoring current version data stored on at least one first server. The current version data may be associated with a current version of a configuration file. The first server may be remote from the gateway. The current version data may be modified at the first server. In response to the gateway determining that the current version data stored on the first server has been modified, a configuration service may be invoked to retrieve the current version of the configuration file from at least one repository based on the current version data. The repository may include at least one second server remote from the gateway and the first server. The gateway may store a copy of the current version of the configuration file retrieved by the configuration service. A system and computer program product are also disclosed.

Abstract: Provided is a method for configuring a gateway. The method may include a gateway monitoring current version data stored on at least one first server. The current version data may be associated with a current version of a configuration file. The first server may be remote from the gateway. The current version data may be modified at the first server. In response to the gateway determining that the current version data stored on the first server has been modified, a configuration service may be invoked to retrieve the current version of the configuration file from at least one repository based on the current version data. The repository may include at least one second server remote from the gateway and the first server. The gateway may store a copy of the current version of the configuration file retrieved by the configuration service. A system and computer program product are also disclosed.

Abstract: The present disclosure relates to oligonucleotide sequences for amplification primers and their use in performing nucleic acid amplifications of HCV, in particular regions that encode the NS3 polypeptide. In some embodiments the primers are used in nested PCR methods for the detection or sequencing of HCV NS3. The oligonucleotide sequences are also provided assembled as kits that can be used to amplify and detect or sequence HCV NS3.

Abstract: The present disclosure relates to oligonucleotide sequences for amplification primers and their use in performing nucleic acid amplifications of HCV, in particular regions that encode the NS3 polypeptide. In some embodiments the primers are used in nested PCR methods for the detection or sequencing of HCV NS3. The oligonucleotide sequences are also provided assembled as kits that can be used to amplify and detect or sequence HCV NS3.

Abstract: The present invention is based in part on the present inventors' appreciation that certain sequences within an HIV genome are more likely to successfully detect HIV across a breadth of HIV variants. The ability to detect and/or quantify the presence and/or load of HIV in a subject is important to, among other things, the diagnosis and treatment of infected individuals. The present invention is based, in part, on the discovery of oligonucleotide reagents that detectably amplify sequences from a greater breadth of HIV samples than certain prior reagents and/or that generate amplicons from HIV genomes from which certain prior reagents would not have generated amplicons. Oligonucleotide reagents as described herein provide unexpected benefits in the detection and/or quantification of the presence and/or load of HIV in a subject, and thereby in the diagnosis and treatment of HIV.

Abstract: Traditionally, enriching or isolating rare circulating cells from a sample has proven difficult as rare circulating cells can be heterogeneous, which limits the use of techniques based on biological properties (e.g., cell surface markers), and can be flexible, which hinders techniques based on physical properties (e.g., diameter size). Methods disclosed herein are capable of enriching or isolating rare circulating cells are minimally impacted by heterogeneity or flexibility of rare circulating cells, and therefore, overcome disadvantages observed with prior techniques. For example, a method for enriching or isolating rare circulating cells from a sample of a subject including fixing one or more rare circulating cells in a sample to create a fixed sample, and isolating the one or more rare circulating cell from the fixed sample using a size exclusion technique is disclosed.

Abstract: Provided is a method for configuring a gateway. The method may include a gateway monitoring current version data stored on at least one first server. The current version data may be associated with a current version of a configuration file. The first server may be remote from the gateway. The current version data may be modified at the first server. In response to the gateway determining that the current version data stored on the first server has been modified, a configuration service may be invoked to retrieve the current version of the configuration file from at least one repository based on the current version data. The repository may include at least one second server remote from the gateway and the first server. The gateway may store a copy of the current version of the configuration file retrieved by the configuration service. A system and computer program product are also disclosed.

Abstract: The present invention is based in part on the present inventors' appreciation that certain sequences within an HIV genome are more likely to successfully detect HIV across a breadth of HIV variants. The ability to detect and/or quantify the presence and/or load of HIV in a subject is important to, among other things, the diagnosis and treatment of infected individuals. The present invention is based, in part, on the discovery of oligonucleotide reagents that detectably amplify sequences from a greater breadth of HIV samples than certain prior reagents and/or that generate amplicons from HIV genomes from which certain prior reagents would not have generated amplicons. Oligonucleotide reagents as described herein provide unexpected benefits in the detection and/or quantification of the presence and/or load of HIV in a subject, and thereby in the diagnosis and treatment of HIV.

Abstract: Traditionally, enriching or isolating rare circulating cells from a sample has proven difficult as rare circulating cells can be heterogeneous, which limits the use of techniques based on biological properties (e.g., cell surface markers), and can be flexible, which hinders techniques based on physical properties (e.g., diameter size). Methods disclosed herein are capable of enriching or isolating rare circulating cells are minimally impacted by heterogeneity or flexibility of rare circulating cells, and therefore, overcome disadvantages observed with prior techniques. For example, a method for enriching or isolating rare circulating cells from a sample of a subject including fixing one or more rare circulating cells in a sample to create a fixed sample, and isolating the one or more rare circulating cell from the fixed sample using a size exclusion technique is disclosed.

Abstract: The present disclosure relates to oligonucleotide sequences for amplification primers and their use in performing nucleic acid amplifications of HCV, in particular regions that encode the NS3 polypeptide. In some embodiments the primers are used in nested PCR methods for the detection or sequencing of HCV NS3. The oligonucleotide sequences are also provided assembled as kits that can be used to amplify and detect or sequence HCV NS3.

Abstract: The present disclosure relates to oligonucleotide sequences for amplification primers and their use in performing nucleic acid amplifications of HCV, in particular regions that encode the NS3 polypeptide. In some embodiments the primers are used in nested PCR methods for the detection or sequencing of HCV NS3. The oligonucleotide sequences are also provided assembled as kits that can be used to amplify and detect or sequence HCV NS3.

Abstract: This invention relates to isolated nucleic acids comprising genes of human chromosome 12q23-qter and the proteins encoded by these genes. Expression vectors and host cells containing such genes or fragments thereof, as well as antibodies to the proteins encoded by these nucleic acids are also included herein.

Abstract: The present disclosure relates to oligonucleotide sequences for amplification primers and their use in performing nucleic acid amplifications of HIV, in particular regions that encode the V3 region of the env glycoprotein. In some embodiments the primers are used in nested PCR methods for the detection or sequencing of the V3 region of the env glycoprotein. The oligonucleotide sequences are also provided assembled as kits that can be used to detect or sequence the V3 region of the env glycoprotein. Control nucleic acids for use in methods and kits of the present disclosure are also provided.

Abstract: This invention relates to isolated nucleic acids comprising genes of human chromosome 12q23-qter and the proteins encoded by these genes. Expression vectors and host cells containing such genes or fragments thereof, as well as antibodies to the proteins encoded by these nucleic acids are also included herein.

Abstract: In accordance with embodiments of the present disclosure, a method may include extracting an operating system install image from a source installation package. The method may also include receiving target information regarding information handling resources of a target information handling system. The method may further include generating executable custom scripts based on an identity of the operating system and the target information, the custom scripts configured to, when executed by the target information handling system, initiate execution of the operating system install image and perform target information handling system-based customizations to the operating system based on the target information.

Abstract: In accordance with embodiments of the present disclosure, a method may include extracting an operating system install image from a source installation package. The method may also include receiving target information regarding information handling resources of a target information handling system. The method may further include generating executable custom scripts based on an identity of the operating system and the target information, the custom scripts configured to, when executed by the target information handling system, initiate execution of the operating system install image and perform target information handling system-based customizations to the operating system based on the target information.

Abstract: This invention relates to isolated nucleic acids comprising genes of human chromosome 12q23-qter and the proteins encoded by these genes. Expression vectors and host cells containing such genes or fragments thereof, as well as antibodies to the proteins encoded by these nucleic acids are also included herein.